Literature DB >> 12482615

Hepatocyte growth factor: from diagnosis to clinical applications.

Hiroshi Funakoshi1, Toshikazu Nakamura.   

Abstract

Hepatocyte growth factor (HGF), initially identified and molecularly cloned as a potent mitogen of primary cultured hepatocytes, has multiple activities in a variety of tissues during the course of development and also in various disease states. HGF plays key roles in the attenuation of disease progression as an intrinsic repair factor. It is also evident that HGF levels are regulated under different conditions, for example, during the course of pregnancy, aging, and disease. This review focuses on the levels of HGF in normal and pathophysiological situations and examines the relationships between HGF levels and disease, disease stage, and disease prognosis. The clinical potential of HGF as a treatment for subjects with various diseases is also given attention.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482615     DOI: 10.1016/s0009-8981(02)00302-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  37 in total

1.  Antifibrotic role of HGF in sarcoidosis.

Authors:  Martin Faehling; Martin Hetzel; Diana Anders; Gerlinde Trischler; Max Bachem
Journal:  Lung       Date:  2012-02-05       Impact factor: 2.584

2.  Distinct recruitment of Eps15 via Its coiled-coil domain is required for efficient down-regulation of the met receptor tyrosine kinase.

Authors:  Christine A Parachoniak; Morag Park
Journal:  J Biol Chem       Date:  2008-12-24       Impact factor: 5.157

Review 3.  Human Breast Milk: Bioactive Components, from Stem Cells to Health Outcomes.

Authors:  Flaminia Bardanzellu; Diego Giampietro Peroni; Vassilios Fanos
Journal:  Curr Nutr Rep       Date:  2020-03

4.  Trans-ethnic meta-analysis identifies common and rare variants associated with hepatocyte growth factor levels in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Nicholas B Larson; Cecilia Berardi; Paul A Decker; Christina L Wassel; Phillip S Kirsch; James S Pankow; Michele M Sale; Mariza de Andrade; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Michael Y Tsai; Kent D Taylor; Suzette J Bielinski
Journal:  Ann Hum Genet       Date:  2015-05-22       Impact factor: 1.670

5.  Prevention of neutrophil extravasation by hepatocyte growth factor leads to attenuations of tubular apoptosis and renal dysfunction in mouse ischemic kidneys.

Authors:  Shinya Mizuno; Toshikazu Nakamura
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

6.  Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Michael P Bancks; Suzette J Bielinski; Paul A Decker; Naomi Q Hanson; Nicholas B Larson; Hugues Sicotte; Christina L Wassel; James S Pankow
Journal:  Metabolism       Date:  2015-10-21       Impact factor: 8.694

7.  Autocrine expression of hepatocyte growth factor and its cytoprotective effect on hepatocyte poisoning.

Authors:  Yong He; Jun Zhou; Ke-Feng Dou; Yong Chen; Qing-Guo Yan; Hai-Min Li
Journal:  World J Gastroenterol       Date:  2004-10-01       Impact factor: 5.742

8.  Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy.

Authors:  Hyori Kim; Jeonghwan Youk; Yaewon Yang; Tae-Yong Kim; Ahrum Min; Hye-Seon Ham; Seongcheol Cho; Kyung-Hun Lee; Bhumsuk Keam; Sae-Won Han; Do-Youn Oh; Han Suk Ryu; Wonshik Han; In Ae Park; Tae-You Kim; Dong-Young Noh; Seock-Ah Im
Journal:  J Cancer Res Clin Oncol       Date:  2015-11-18       Impact factor: 4.553

Review 9.  Pleural mesothelial cells in pleural and lung diseases.

Authors:  Hitesh Batra; Veena B Antony
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

10.  Effect of hepatocyte growth factor (HGF) on the level of Survivin & XIAP expression in several human cancer cell lines, after treating with DNA damaging agent.

Authors:  Kianoosh Keyhanian; Rosita Edalat; Akbar Oghalaei; Nayere Askary; Arghavan Golshani; Mansour Salehi; Ramin Sarrami-Forooshani; Mohammad Ali Shokrgozar
Journal:  Mol Cell Biochem       Date:  2007-05-30       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.